Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP477825.RADvmxlKD0Hp8adrFD-Jw1WWKkAjYn3zP9gtZ4qV57bsE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP477825.RADvmxlKD0Hp8adrFD-Jw1WWKkAjYn3zP9gtZ4qV57bsE130_assertion type Assertion NP477825.RADvmxlKD0Hp8adrFD-Jw1WWKkAjYn3zP9gtZ4qV57bsE130_head.
- NP477825.RADvmxlKD0Hp8adrFD-Jw1WWKkAjYn3zP9gtZ4qV57bsE130_assertion description "[At multivariate analysis, cancer-related survival was associated with Dukes' stage (p<0.0001), CEA level (p=0.02), and mutant circulating KRAS2 (p=0.01).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP477825.RADvmxlKD0Hp8adrFD-Jw1WWKkAjYn3zP9gtZ4qV57bsE130_provenance.
- NP477825.RADvmxlKD0Hp8adrFD-Jw1WWKkAjYn3zP9gtZ4qV57bsE130_assertion evidence source_evidence_literature NP477825.RADvmxlKD0Hp8adrFD-Jw1WWKkAjYn3zP9gtZ4qV57bsE130_provenance.
- NP477825.RADvmxlKD0Hp8adrFD-Jw1WWKkAjYn3zP9gtZ4qV57bsE130_assertion SIO_000772 17177160 NP477825.RADvmxlKD0Hp8adrFD-Jw1WWKkAjYn3zP9gtZ4qV57bsE130_provenance.
- NP477825.RADvmxlKD0Hp8adrFD-Jw1WWKkAjYn3zP9gtZ4qV57bsE130_assertion wasDerivedFrom befree-20140225 NP477825.RADvmxlKD0Hp8adrFD-Jw1WWKkAjYn3zP9gtZ4qV57bsE130_provenance.
- NP477825.RADvmxlKD0Hp8adrFD-Jw1WWKkAjYn3zP9gtZ4qV57bsE130_assertion wasGeneratedBy ECO_0000203 NP477825.RADvmxlKD0Hp8adrFD-Jw1WWKkAjYn3zP9gtZ4qV57bsE130_provenance.